Sunny Pharmtech Inc. (TPEX:6676)

Sunny Pharmtech Statistics

Total Valuation

Sunny Pharmtech has a market cap or net worth of TWD 2.21 billion. The enterprise value is 2.62 billion.

Market Cap	2.21B
Enterprise Value	2.62B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Sunny Pharmtech has 148.82 million shares outstanding. The number of shares has increased by 0.15% in one year.

Current Share Class	148.82M
Shares Outstanding	148.82M
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	17.67%
Owned by Institutions (%)	3.56%
Float	105.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.73
PB Ratio	2.93
P/TBV Ratio	3.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.67
EV / Sales	10.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.91

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.61.

Current Ratio	0.91
Quick Ratio	0.44
Debt / Equity	0.61
Debt / EBITDA	n/a
Debt / FCF	-2.46
Interest Coverage	-30.65

Financial Efficiency

Return on equity (ROE) is -33.53% and return on invested capital (ROIC) is -14.97%.

Return on Equity (ROE)	-33.53%
Return on Assets (ROA)	-13.27%
Return on Invested Capital (ROIC)	-14.97%
Return on Capital Employed (ROCE)	-28.08%
Weighted Average Cost of Capital (WACC)	5.17%
Revenue Per Employee	1.60M
Profits Per Employee	-1.91M
Employee Count	158
Asset Turnover	0.17
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.74% in the last 52 weeks. The beta is 0.30, so Sunny Pharmtech's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+5.74%
50-Day Moving Average	14.99
200-Day Moving Average	15.19
Relative Strength Index (RSI)	56.50
Average Volume (20 Days)	291,332

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sunny Pharmtech had revenue of TWD 253.01 million and -302.05 million in losses. Loss per share was -2.03.

Revenue	253.01M
Gross Profit	73.14M
Operating Income	-317.53M
Pretax Income	-302.05M
Net Income	-302.05M
EBITDA	-189.95M
EBIT	-317.53M
Loss Per Share	-2.03

Balance Sheet

The company has 54.87 million in cash and 463.62 million in debt, with a net cash position of -408.76 million or -2.75 per share.

Cash & Cash Equivalents	54.87M
Total Debt	463.62M
Net Cash	-408.76M
Net Cash Per Share	-2.75
Equity (Book Value)	754.95M
Book Value Per Share	5.07
Working Capital	-24.62M

Cash Flow

In the last 12 months, operating cash flow was -158.99 million and capital expenditures -29.33 million, giving a free cash flow of -188.32 million.

Operating Cash Flow	-158.99M
Capital Expenditures	-29.33M
Depreciation & Amortization	127.58M
Net Borrowing	98.08M
Free Cash Flow	-188.32M
FCF Per Share	-1.27

Margins

Gross margin is 28.91%, with operating and profit margins of -125.50% and -119.38%.

Gross Margin	28.91%
Operating Margin	-125.50%
Pretax Margin	-119.38%
Profit Margin	-119.38%
EBITDA Margin	-75.08%
EBIT Margin	-125.50%
FCF Margin	n/a

Dividends & Yields

Sunny Pharmtech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.15%
Shareholder Yield	-0.15%
Earnings Yield	-13.67%
FCF Yield	-8.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2